Everything below concerns Beta isomer. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a pyridine nucleotide that consists of a nicotinamide ring, a ribose sugar, and a phosphate group. It is an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+, synthesis. In mammalian cells, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. Nicotinamide mononucleotide adenylyltransferases then convert NMN into NAD+. The core structure and enzymatic route are well established in biochemical literature.
The biologically relevant form of NMN is generally the beta anomer, which is recognized by NMN adenylyltransferases. NMN is polar and water soluble, and it does not readily diffuse across lipid membranes without assistance. Whether intact NMN enters cells through a specific transporter remains an open question; some studies propose solute carrier family members, while other work favors extracellular dephosphorylation to nicotinamide riboside followed by uptake. This transport and compartmentalization debate affects how researchers interpret oral administration studies. The distinction between intracellular synthesis and extracellular delivery is central to current discussion.
The term NMN commonly refers to the beta isomer, in which the nicotinamide group is attached to the ribose through a beta-glycosidic bond. Commercial material may be supplied as the free acid or as a salt, such as a sodium salt, which affects molecular weight and water solubility. Related compounds include nicotinamide riboside and NAD+ itself, but these are distinct molecules with different formulas and cellular handling. Laboratory research often uses the beta form because it matches the naturally occurring configuration found in biological systems.
Small amounts of NMN occur in some foods, including certain vegetables, fruits, and animal products, though the quantities are generally low and variable. Human cells also synthesize NMN internally from nicotinamide and other precursors. Research interest increased after studies examined whether raising NAD+ levels affects metabolism and aging-related pathways in animals. Evidence in humans remains limited and mixed for many outcomes, and questions about effective absorption, tissue delivery, and long-term effects are still open. Regulatory status differs by country, with some markets treating NMN as a supplement ingredient and others restricting its sale.
| Property | Value | Notes |
|---|---|---|
| Systematic class | Pyridine nucleotide | Contains nicotinamide, ribose, and phosphate |
| Common form | beta-NMN | Anomeric configuration relevant to enzyme recognition |
| Molecular formula | C11H15N2O8P | As the free acid |
| Molar mass | 334.22 g/mol | Calculated for the free acid |
| CAS Registry Number | 1094-61-7 | Commonly associated with beta-D-NMN |
NMN occurs in many living systems, including bacteria, yeast, plants, and mammals. Dietary sources are present in foods such as edamame, avocado, broccoli, and various meats, but amounts vary widely and are generally lower than those used in research settings. Laboratory production often relies on enzymatic synthesis or chemical phosphorylation of nicotinamide riboside, and commercial material is typically supplied as a white to off-white powder. Because NMN is hygroscopic and sensitive to heat, moisture, and pH extremes, its handling requires care to preserve identity and purity. Aqueous preparation should be done with attention to pH and temperature to limit hydrolysis.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure consists of a nicotinamide ring linked to ribose phosphate, and the compound serves as an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+. In this pathway, nicotinamide phosphoribosyltransferase converts nicotinamide and phosphoribosyl pyrophosphate into NMN, after which NMN adenylyltransferase attaches an adenylate group to produce NAD+. Because NAD+ participates in redox reactions and signaling, NMN occupies a central position in cellular metabolism. The molecule is distinct from nicotinamide riboside, though the two are related in NAD+ precursor research.
Beyond its intracellular synthesis, NMN can be taken up from the extracellular environment, although the routes are still debated. Some evidence points to direct transport into cells through specific transporters, while other work suggests dephosphorylation to nicotinamide riboside followed by cellular uptake. Once inside, NMN can be converted to NAD+ by NMN adenylyltransferases; the relative contribution of these routes may differ by tissue, species, and experimental conditions. Researchers continue to investigate which mechanisms dominate in intact organisms and how they affect measured NAD+ levels. Direct measurement in tissues remains technically challenging because NMN can be rapidly metabolized during sample collection.
Research on NMN has focused on aging, metabolic regulation, exercise capacity, and insulin sensitivity, but findings are preliminary. Many human trials are small, short in duration, and use different endpoints, which complicates comparison across studies. No national regulator has approved NMN as a therapeutic drug for any indication. In some countries it is sold as a supplement or research chemical, while other jurisdictions have questioned its status under food or supplement laws. Claims about extending human lifespan or reversing aging are not supported by established clinical evidence.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms, including bacteria, plants, and mammals. Its structure consists of a nicotinamide ring attached to a ribose-phosphate group. NMN functions as an intermediate in the NAD+ salvage pathway, a recycling route that regenerates nicotinamide adenine dinucleotide. The enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+.
The SCN coordinates daily timekeeping in the body and VIP plays a key role in communication between individual brain cells within this region. At a cellular level, the SCN expresses different electrical activity in circadian time. Higher activity is observed during the day, while during night there is lower activity. This rhythm is thought to be important feature of SCN to synchronize with each other and control rhythmicity in other regions. VIP acts as a major synchronizing agent among SCN neurons and plays a role in synchronizing the SCN with light cues. The high concentration of VIP and VIP receptor containing neurons are primarily found in the ventrolateral aspect of the SCN, which is also located above the optic chiasm. The neurons in this area receive retinal information from the retinohypothalamic tract and then relay the environmental information to the SCN. Further, VIP is also involved in synchronizing the timing of SCN function with the environmental light-dark cycle. Combined, these roles in the SCN make VIP a crucial component of the mammalian circadian timekeeping machinery. After finding evidence of VIP in the SCN, researchers began contemplating its role within the SCN and how it could affect circadian rhythm. The VIP also plays a pivotal role in modulating oscillations. Previous pharmacological research has established that VIP is needed for normal light-induced synchronization of the circadian systems. Application of VIP also phase shifts the circadian rhythm of vasopressin release and neural activity.
== Chemistry == The chemical structure of suvomipic was originally undisclosed for a time. The drug has been patented and its structure was initially said to be known only to Pelage Pharmaceuticals. The company has also patented and published on other MPC inhibitors such as JXL069 and JXL082. They are (E)-2-cyano-3-(1H-indol-3-yl)acrylic acids and related analogues. Suvomipic was said to be neither JXL069 nor JXL082. The drug-related properties of certain related MPC inhibitors like UK-5099 (JXL001) are said to be incompatible with therapeutic use. In July 2026, the INNTooltip International Nonproprietary Name of suvomipic was published and revealed it to in fact be JXL069.
== Personal life == On 5 July 2008, Emma Griffiths married Busted member Matt Willis at Rushton Hall, Northamptonshire, after three years of dating. The wedding was featured in OK magazine. She gave birth to their first child, a daughter named Isabelle, on 20 June 2009. On 25 November 2011, the couple had a second child, a son named Ace. On 4 May 2016, Willis gave birth to their third child, a second daughter, named Trixie Grace. In an episode of Who Do You Think You Are?, Willis confirmed that she has longstanding roots in Birmingham, with her family tree being traced back to her great-great-great-grandfather, who was named James Gretton and was listed as a Horn and Hair Merchant in the census records. She also found she had Irish ancestors, a fact that came as a surprise to her. The revelations about her ancestry left her extremely uncomfortable with the actions of one, who she discovered was a violent Orangeman, but overall, she was happy to have found a connection to her more broad Irish heritage. Willis is a supporter of Aston Villa. In August 2019, Willis obtained a qualification as a maternity care assistant following her experience on the W series Delivering Babies. During the COVID-19 pandemic in March 2021, Willis and her husband completed training with St John Ambulance to act as vaccination volunteers. In May 2023, Willis was featured in the documentary, Matt Willis: Fighting Addiction. The documentary, which aired on the BBC on 17 May 2023, followed Willis and her husband as they spoke about the latter's addiction issues.
Many types of breeder reactor are possible: A "breeder" is simply a nuclear reactor designed for very high neutron economy with an associated conversion ratio higher than 1.0. In principle, almost any reactor design could be tweaked to become a breeder. For example, the reduced-moderation water reactor concept uses mixed-oxide fuel in a tight lattice to increase the conversion ratio. Aside from water-cooled, there are many other types of breeder reactor currently envisioned as possible. These include molten-salt cooled, gas cooled, and liquid-metal cooled designs in many variations. Almost any of these basic design types may be fueled by uranium, plutonium, many minor actinides, or thorium, and they may be designed for many different goals, such as creating more fissile fuel, long-term steady-state operation, or active burning of nuclear wastes. Extant reactor designs are sometimes divided into two broad categories based upon their neutron spectrum, which generally separates those designed to use primarily uranium and transuranics from those designed to use thorium and avoid transuranics. These designs are:
Sources: en.wikipedia.org
Liu Wenhui entered the Xikang area with around ten to twenty thousand troops of the 24th Army at his disposal, equipped with automatic weapons, mortars, and artillery. The size and strength of Liu's remaining forces, even in this diminished state, gave him much authority in dealing with local elites and in pacifying the province. To strengthen control over the local tusi of Kham, Liu ordered from 1932 onwards that all local tribal soldiers be integrated directly into the 24th Army, a measure that reportedly maintained peace in the region.
To promote better consistency between a trial's objective and analysis methods, the International Committee for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has published a new international trial regulatory guidance in Nov 2019, the ICH E9(R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials. The guidance calls for clearly defining the research question of a trial by specifying its estimand. An estimand is a clear description of the treatment effect a trial aims to quantify. The guidance provides a structured framework for defining estimands, which consists of five attributes: (i) population of patients; (ii) treatment conditions being compared; (iii) the endpoint; (iv) the summary measure; and (v) how intercurrent events are handled. Tutorials on how to implement the estimand framework is available.
=== Coenzymes === Coenzymes are small organic molecules that can be loosely or tightly bound to an enzyme. Coenzymes transport chemical groups from one enzyme to another. Examples include NADH, NADPH and adenosine triphosphate (ATP). Some coenzymes, such as flavin mononucleotide (FMN), flavin adenine dinucleotide (FAD), thiamine pyrophosphate (TPP), and tetrahydrofolate (THF), are derived from vitamins. These coenzymes cannot be synthesized by the body de novo and closely related compounds (vitamins) must be acquired from the diet. The chemical groups carried include:
Recently, the MMP3 gene was shown to be down-regulated in individuals with cleft lip and palate when compared to controls, reinforcing the nature of cleft lip/palate as a condition resulting from insufficient or defective embryonic tissue remodeling.
Animals are multicellular, eukaryotic organisms belonging to the biological kingdom Animalia (). Animals consume organic material, breathe oxygen, have muscle cells, can reproduce sexually, and grow from a hollow sphere of cells, the blastula, during embryonic development. With few exceptions, animals are able to move. Animals form a clade, meaning that they arose from a single common ancestor. Over 1.5 million living animal species have been described, of which around 1.05 million are insects, over 85,000 are molluscs, and around 65,000 are vertebrates. It has been estimated there are as many as 7.77 million animal species on Earth. Animal body lengths range from 8.5 μm (0.00033 in) to 33.6 m (110 ft). They have complex ecologies and interactions with each other and their environments, forming intricate food webs. The scientific study of animals is known as zoology, and the study of animal behaviour is known as ethology. The animal kingdom is divided into five major clades, namely Porifera, Ctenophora, Placozoa, Cnidaria and Bilateria. Most living animal species belong to the clade Bilateria, a highly proliferative clade whose members have a bilaterally symmetric and significantly cephalised body plan, and the vast majority of bilaterians belong to two large clades: the protostomes, which include organisms such as arthropods, molluscs, flatworms, annelids and nematodes; and the deuterostomes, which include echinoderms, hemichordates and chordates, the last of which contains the vertebrates.
Sources: en.wikipedia.org
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide intermediate in NAD+ biosynthesis.
NMN is a direct precursor in the salvage pathway that produces NAD+. Enzymes called NMN adenylyltransferases convert NMN into NAD+, a coenzyme involved in redox reactions and signaling.
No. Nicotinamide riboside is a related compound that lacks the phosphate group present in NMN. Both can influence NAD+ pathways, but their structures, transport, and metabolism differ.
NMN stands for nicotinamide mononucleotide. It is a nucleotide composed of nicotinamide, ribose, and phosphate. In cells, it is an intermediate in NAD+ biosynthesis.